Abhishek Goyal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Abhishek Goyal has a total of 127 co-authors. Here are the top co-authors by number of shared publications:
Alkesh Khurana
Department of Pulmonary Medicine, All India Institute of Medical Sciences (AIIMS), Bhopal, India
20 shared publicationsAbhijit Pakhare
15 shared publications- Abhijit Patilbuwa Pakhare
Department of Community and family Medicine, All India Institute of Medical Sciences Bhopal, Bhopal, India
9 shared publications Ankur Joshi
Department of Community Medicine, AIIMS Bhopal, Bhopal, India
8 shared publicationsAvishek Kar
Department of Pulmonary Medicine, AIIMS, Bhopal, Madhya Pradesh, India
8 shared publicationsKhushboo Saxena
Department of Pulmonary Medicine, AIIMS, Bhopal, Madhya Pradesh, India
8 shared publications
Latest Publications
- 9 October 2026
- Published by Springer Nature in Sleep and Vigilance
- p. 1-6
Restless Legs Syndrome and Insomnia Among COVID-19 Survivors: A Cross-Sectional Multicentre Study
- 9 October 2026
- Published by Springer Nature in Sleep and Vigilance
- p. 1-6
Restless Legs Syndrome and Insomnia Among COVID-19 Survivors: A Cross-Sectional Multicentre Study
- Open Access
- 29 August 2026
- Published by Wolters Kluwer Health in Lung India
- Vol. 43 (5) , 561-565
Day-time split study for management of obstructive sleep apnoea: Proof of concept study
Objective: Waiting time for diagnosis and treatment of obstructive sleep apnoea (OSA) is increasing due to a lack of adequate amount of sleep labs. This study was done to find out the feasibility of daytime split Polysomnography (PSG) in patients with excessive daytime sleepiness (EDS) so as to reduce waiting time in sleep labs. Methods: Thirty patients with EDS (defined by Epworth Sleepiness scale ≥14) underwent both dPSG (daytime) and nPSG (nighttime). Diagnostic sleep parameters, titration pressures were compared. A questionnaire consisting of 12 questions for the experience of patients, technicians, and physicians was filled out after each dPSG and nPSG. Results: Thirty patients (11 females and 19 males) underwent both dPSG and NPSG. The mean age and BMI were 55.23 ± 8.1 years and 36.11 ± 7.70 kg/m², respectively. PSG parameters (sleep efficiency, total sleep time, time in bed) were not different in the two groups. During dPSG titration, optimal, good and adequate titration was achieved in 22%, 19% and 52% respectively, compared to 33%, 15% and 44% during nPSG. In the Likert scale questionnaire, patients had comparable sleep quality in both PSGs. Technicians felt more sleepy during nPSG, and most technicians preferred dPSG over nPSG. Physicians’ agreement with titration done by technicians was equal in both dPSG and nPSG. Conclusions: Daytime split PSG may be a viable alternative to night PSG in patients with OSA with excessive sleepiness. This can ensure early treatment of patients with OSA.
- 29 August 2026
- Published by Wolters Kluwer Health in Lung India
- Vol. 43 (5) , 561-565
Open AccessDay-time split study for management of obstructive sleep apnoea: Proof of concept study
Objective: Waiting time for diagnosis and treatment of obstructive sleep apnoea (OSA) is increasing due to a lack of adequate amount of sleep labs. This study was done to find out the feasibility of daytime split Polysomnography (PSG) in patients with excessive daytime sleepiness (EDS) so as to reduce waiting time in sleep labs. Methods: Thirty patients with EDS (defined by Epworth Sleepiness scale ≥14) underwent both dPSG (daytime) and nPSG (nighttime). Diagnostic sleep parameters, titration pressures were compared. A questionnaire consisting of 12 questions for the experience of patients, technicians, and physicians was filled out after each dPSG and nPSG. Results: Thirty patients (11 females and 19 males) underwent both dPSG and NPSG. The mean age and BMI were 55.23 ± 8.1 years and 36.11 ± 7.70 kg/m², respectively. PSG parameters (sleep efficiency, total sleep time, time in bed) were not different in the two groups. During dPSG titration, optimal, good and adequate titration was achieved in 22%, 19% and 52% respectively, compared to 33%, 15% and 44% during nPSG. In the Likert scale questionnaire, patients had comparable sleep quality in both PSGs. Technicians felt more sleepy during nPSG, and most technicians preferred dPSG over nPSG. Physicians’ agreement with titration done by technicians was equal in both dPSG and nPSG. Conclusions: Daytime split PSG may be a viable alternative to night PSG in patients with OSA with excessive sleepiness. This can ensure early treatment of patients with OSA.
- 19 June 2026
- Published by Elsevier in Sleep Medicine
- Vol. 146, 109091
Comprehensive evaluation of secondary causes of hypertension: Integrated screening for obstructive sleep apnea and primary aldosteronism
- 19 June 2026
- Published by Elsevier in Sleep Medicine
- Vol. 146, 109091
Comprehensive evaluation of secondary causes of hypertension: Integrated screening for obstructive sleep apnea and primary aldosteronism
- Open Access
- 28 May 2026
- Published by Elsevier in SSRN Electronic Journal
Projecting the Burden of Obstructive Sleep Apnoea in India till 2100
Background: Obstructive sleep apnoea (OSA) is a rapidly expanding public health concern globally. India, with the world’s largest population, lacks prospective long-term burden projections for OSA. We aimed to project the prevalence and absolute case burden of OSA (apnoea–hypopnoea index ≥15 events/hour) in India from 2019 to 2100. Methods: For prospective prediction modelling, the BLESS cohort (N=965) was used, incorporating age, BMI, and gender as predictors. A Bayesian logistic regression framework enabled posterior coefficient sampling. Individual-level predicted risks were applied to merged NFHS-5 and LASI Wave-1 datasets (N=676445), stratified by age-sex strata, and multiplied by UN population projections (2019–2100). Three BMI scenarios were tested: Reference (no BMI change), Gradual (modest increase in BMI), and accelerated (continued obesity growth). Uncertainty was propagated through 2,000 Monte Carlo simulations, generating 95% uncertainty intervals (UI). Results: In 2019, estimated moderate-to-severe OSA prevalence was 28.9% (95% UI: 25.9–32.2%), equivalent to approximately 267 million cases. Under the reference, gradual, and accelerated scenarios, prevalence is expected to rise to 36.7% (∼401 million cases), 44.7% (∼489 million cases), & 48.9% (∼534 million cases) by 2100, respectively. OSA prevalence is expected to peak at approximately 459 million (2070), 563 million (2070), and 619 million (2060) cases in reference, gradual, and accelerated scenarios, respectively. Interpretation: India faces an enormous and growing OSA burden over the coming decades, driven by demographic ageing and rising obesity. OSA must be urgently integrated into India’s non-communicable disease framework, with substantial expansion of diagnostic infrastructure
- 28 May 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessProjecting the Burden of Obstructive Sleep Apnoea in India till 2100
Background: Obstructive sleep apnoea (OSA) is a rapidly expanding public health concern globally. India, with the world’s largest population, lacks prospective long-term burden projections for OSA. We aimed to project the prevalence and absolute case burden of OSA (apnoea–hypopnoea index ≥15 events/hour) in India from 2019 to 2100. Methods: For prospective prediction modelling, the BLESS cohort (N=965) was used, incorporating age, BMI, and gender as predictors. A Bayesian logistic regression framework enabled posterior coefficient sampling. Individual-level predicted risks were applied to merged NFHS-5 and LASI Wave-1 datasets (N=676445), stratified by age-sex strata, and multiplied by UN population projections (2019–2100). Three BMI scenarios were tested: Reference (no BMI change), Gradual (modest increase in BMI), and accelerated (continued obesity growth). Uncertainty was propagated through 2,000 Monte Carlo simulations, generating 95% uncertainty intervals (UI). Results: In 2019, estimated moderate-to-severe OSA prevalence was 28.9% (95% UI: 25.9–32.2%), equivalent to approximately 267 million cases. Under the reference, gradual, and accelerated scenarios, prevalence is expected to rise to 36.7% (∼401 million cases), 44.7% (∼489 million cases), & 48.9% (∼534 million cases) by 2100, respectively. OSA prevalence is expected to peak at approximately 459 million (2070), 563 million (2070), and 619 million (2060) cases in reference, gradual, and accelerated scenarios, respectively. Interpretation: India faces an enormous and growing OSA burden over the coming decades, driven by demographic ageing and rising obesity. OSA must be urgently integrated into India’s non-communicable disease framework, with substantial expansion of diagnostic infrastructure
- 6 April 2026
- Published by Springer Nature in Sleep and Vigilance
- Vol. 10 (1) , 1-3
Polycythemia in Obstructive Sleep Apnea: Prevalence, Predictors, and Clinical Implications Using WHO 2016 Criteria
- 6 April 2026
- Published by Springer Nature in Sleep and Vigilance
- Vol. 10 (1) , 1-3
Polycythemia in Obstructive Sleep Apnea: Prevalence, Predictors, and Clinical Implications Using WHO 2016 Criteria
- 8 November 2025
- Published by Springer Nature in Sleep and Breathing
- Vol. 29 (6) , 1-11
Obesity,obstructive sleep Apnea, and cardiometabolic risk: A comparative analysis of population-Based cohorts in Switzerland, India, and Benin
Purpose The prevalence and severity of Obstructive Sleep Apnea(OSA) vary by ethnicity, yet data comparing OSA and its anthropometric risk factors across global, population-based cohorts remain limited. We aimed to determine associations between morphological factors and OSA severity, as well as whether OSA-related cardiometabolic risks differ among Swiss, Beninese, and Indian adults. Methods We analyzed pooled data from 4,663 adults enrolled in three population-based sleep cohorts: HypnoLaus(Switzerland), BeSAS(Benin), and BLESS(India). Associations between OSA severity (apnea–hypopnea index, AHI) and anthropometric measures [body mass index (BMI), neck circumference, and waist circumference] were examined using multivariable regression models adjusted for age and sex, with effect modification by cohort assessed. Associations between OSA (AHI ≥ 15) and major cardiometabolic comorbidities (hypertension, diabetes, and metabolic syndrome) were also evaluated. Results For each 1 Kg/m2 increase in BMI, AHI increased by 5.95%, 7.31%, and 8.06% in Beninese, Swiss, and Indians, respectively. OSA was consistently associated with increased odds of hypertension in all populations (OR: 1.30, 1.76, and 1.63 in Swiss, Indian, and Beninese populations, respectively). Moreover, OSA was associated with increased odds of metabolic syndrome [in Swiss (OR:1.64) and Indian (OR: 1.89)]. Conclusions Associations between obesity-related anthropometric factors, OSA severity, and cardiometabolic comorbidities differ across populations, with the strongest relationships observed in the Indian and Swiss cohorts. These findings underscore the importance of population-specific risk stratification and highlight the need to consider local anthropometric and epidemiologic contexts in OSA management and prevention strategies.
- 8 November 2025
- Published by Springer Nature in Sleep and Breathing
- Vol. 29 (6) , 1-11
Obesity,obstructive sleep Apnea, and cardiometabolic risk: A comparative analysis of population-Based cohorts in Switzerland, India, and Benin
Purpose The prevalence and severity of Obstructive Sleep Apnea(OSA) vary by ethnicity, yet data comparing OSA and its anthropometric risk factors across global, population-based cohorts remain limited. We aimed to determine associations between morphological factors and OSA severity, as well as whether OSA-related cardiometabolic risks differ among Swiss, Beninese, and Indian adults. Methods We analyzed pooled data from 4,663 adults enrolled in three population-based sleep cohorts: HypnoLaus(Switzerland), BeSAS(Benin), and BLESS(India). Associations between OSA severity (apnea–hypopnea index, AHI) and anthropometric measures [body mass index (BMI), neck circumference, and waist circumference] were examined using multivariable regression models adjusted for age and sex, with effect modification by cohort assessed. Associations between OSA (AHI ≥ 15) and major cardiometabolic comorbidities (hypertension, diabetes, and metabolic syndrome) were also evaluated. Results For each 1 Kg/m2 increase in BMI, AHI increased by 5.95%, 7.31%, and 8.06% in Beninese, Swiss, and Indians, respectively. OSA was consistently associated with increased odds of hypertension in all populations (OR: 1.30, 1.76, and 1.63 in Swiss, Indian, and Beninese populations, respectively). Moreover, OSA was associated with increased odds of metabolic syndrome [in Swiss (OR:1.64) and Indian (OR: 1.89)]. Conclusions Associations between obesity-related anthropometric factors, OSA severity, and cardiometabolic comorbidities differ across populations, with the strongest relationships observed in the Indian and Swiss cohorts. These findings underscore the importance of population-specific risk stratification and highlight the need to consider local anthropometric and epidemiologic contexts in OSA management and prevention strategies.
- 5 October 2025
- Published by Springer Nature in Sleep and Biological Rhythms
- Vol. 24 (1) , 67-71
Sleep related rhythmic movement disorder treated with positive airway pressure
Sleep-related rhythmic movement disorder (SRMD) in adults is rare, posing a distinctive challenge for healthcare practitioners. These movements can lead to significant disruption in sleep and can be a potential indicator of underlying severe Obstructive Sleep Apnea (OSA). The aim of the study was to evaluate OSA patients presenting with SRMD and their management with positive airway pressure therapy (PAP). Data of patients (aged between 18 and 80 years) with OSA and video documentation of abnormal movements during sleep study were taken from the sleep registry for this study. SRMD was defined as per Polysomnographic scoring rules in the AASM Manual for the Scoring of Sleep and Associated Events. All these patients were treated with PAP therapy. Seven patients were diagnosed as rhythmic movement disorders while being evaluated as cases of obstructive sleep apnea (OSA) during level I polysomnography (PSG). These movements significantly decreased during titration with positive airway pressure. The most frequently seen movements were rhythmic repetitive cyclic leg movements, leg kicking and rolling seen in three patients, followed by head banging in two patients. Combination of more than two movements was present in one patient. These movements significantly decreased with PAP therapy usage during follow-up. OSA is one of the important causes of SRMD in adults. CPAP is effective in treating SRMD associated with sleep apnea, emphasizing the importance of an accurate diagnosis through Level 1 PSG.
- 5 October 2025
- Published by Springer Nature in Sleep and Biological Rhythms
- Vol. 24 (1) , 67-71
Sleep related rhythmic movement disorder treated with positive airway pressure
Sleep-related rhythmic movement disorder (SRMD) in adults is rare, posing a distinctive challenge for healthcare practitioners. These movements can lead to significant disruption in sleep and can be a potential indicator of underlying severe Obstructive Sleep Apnea (OSA). The aim of the study was to evaluate OSA patients presenting with SRMD and their management with positive airway pressure therapy (PAP). Data of patients (aged between 18 and 80 years) with OSA and video documentation of abnormal movements during sleep study were taken from the sleep registry for this study. SRMD was defined as per Polysomnographic scoring rules in the AASM Manual for the Scoring of Sleep and Associated Events. All these patients were treated with PAP therapy. Seven patients were diagnosed as rhythmic movement disorders while being evaluated as cases of obstructive sleep apnea (OSA) during level I polysomnography (PSG). These movements significantly decreased during titration with positive airway pressure. The most frequently seen movements were rhythmic repetitive cyclic leg movements, leg kicking and rolling seen in three patients, followed by head banging in two patients. Combination of more than two movements was present in one patient. These movements significantly decreased with PAP therapy usage during follow-up. OSA is one of the important causes of SRMD in adults. CPAP is effective in treating SRMD associated with sleep apnea, emphasizing the importance of an accurate diagnosis through Level 1 PSG.
- 9 August 2025
- Published by Wiley in Journal of Sleep Research
- Vol. 35 (2) , e70165
Development and Validation of the SONA Questionnaire: A Gender‐Specific Screening Tool for Moderate‐to‐Severe Obstructive Sleep Apnoea
Overnight polysomnography (PSG) poses logistical and financial challenges in resource‐constrained settings for the diagnosis of OSA. This study aimed to develop a simple, effective screening tool for identifying individuals at risk for OSA. Data from 1015 healthy volunteers enrolled in the BLESS cohort were analysed, all of whom underwent Level I PSG. Optimal thresholds for selected demographic, anthropometric and clinical variables were determined using a bootstrapped matrix maximisation method, with apnoea–hypopnoea index (AHI) as the reference. The dataset was split into training ( n = 732) and testing ( n = 244) subsets, and four predictive models were developed. A scoring system, termed SONA, was derived from coefficients of the best‐performing model. Its performance was compared to existing tools. The final model incorporated four variables (AIC = 699.21, BIC = 726.79, pseudo‐ R 2 = 0.36): waist circumference (> 93 cm in males, > 85 cm in females) and neck circumference (> 37 cm in males, > 32 cm in females) assigned 3 points each; age (> 35 years in males, > 45 years in females) assigned 2 points; and presence of snoring assigned 3 points. The total score ranged from 0 to 11. Diagnostic cut‐offs were identified at scores of 5 (i.e., any two variables affirmative) in community settings and 8 (i.e., any three variables affirmative) in hospital settings. At AHI cut‐off of 15, the SONA score demonstrated superior discrimination (AUC = 0.83; p value < 0.001) compared to STOPBANG (0.72), NoSAS (0.77), GOAL (0.74) and the Berlin Questionnaire (0.70). The SONA score offers a simpler, more accurate alternative for OSA screening compared to existing tools and is well‐suited for implementation in primary care and resource‐limited settings.
- 9 August 2025
- Published by Wiley in Journal of Sleep Research
- Vol. 35 (2) , e70165
Development and Validation of the SONA Questionnaire: A Gender‐Specific Screening Tool for Moderate‐to‐Severe Obstructive Sleep Apnoea
Overnight polysomnography (PSG) poses logistical and financial challenges in resource‐constrained settings for the diagnosis of OSA. This study aimed to develop a simple, effective screening tool for identifying individuals at risk for OSA. Data from 1015 healthy volunteers enrolled in the BLESS cohort were analysed, all of whom underwent Level I PSG. Optimal thresholds for selected demographic, anthropometric and clinical variables were determined using a bootstrapped matrix maximisation method, with apnoea–hypopnoea index (AHI) as the reference. The dataset was split into training ( n = 732) and testing ( n = 244) subsets, and four predictive models were developed. A scoring system, termed SONA, was derived from coefficients of the best‐performing model. Its performance was compared to existing tools. The final model incorporated four variables (AIC = 699.21, BIC = 726.79, pseudo‐ R 2 = 0.36): waist circumference (> 93 cm in males, > 85 cm in females) and neck circumference (> 37 cm in males, > 32 cm in females) assigned 3 points each; age (> 35 years in males, > 45 years in females) assigned 2 points; and presence of snoring assigned 3 points. The total score ranged from 0 to 11. Diagnostic cut‐offs were identified at scores of 5 (i.e., any two variables affirmative) in community settings and 8 (i.e., any three variables affirmative) in hospital settings. At AHI cut‐off of 15, the SONA score demonstrated superior discrimination (AUC = 0.83; p value < 0.001) compared to STOPBANG (0.72), NoSAS (0.77), GOAL (0.74) and the Berlin Questionnaire (0.70). The SONA score offers a simpler, more accurate alternative for OSA screening compared to existing tools and is well‐suited for implementation in primary care and resource‐limited settings.